agilon health (NYSE:AGL) Stock Price Down 7.9% on Analyst Downgrade

agilon health, inc. (NYSE:AGL)’s share price fell 7.9% during trading on Tuesday after Stifel Nicolaus lowered their price target on the stock from $7.00 to $2.00. Stifel Nicolaus currently has a hold rating on the stock. agilon health traded as low as $1.99 and last traded at $1.99. 1,089,524 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 4,947,120 shares. The stock had previously closed at $2.16.

AGL has been the subject of several other research reports. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research note on Wednesday, October 2nd. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Citigroup restated a “sell” rating and set a $2.50 price target (down from $7.00) on shares of agilon health in a research note on Tuesday, October 29th. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $7.03.

Insider Buying and Selling

In other news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction on Thursday, September 12th. The shares were acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 3.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Swiss National Bank boosted its stake in shares of agilon health by 0.6% in the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock valued at $3,677,000 after purchasing an additional 3,400 shares in the last quarter. Bleakley Financial Group LLC bought a new position in shares of agilon health during the first quarter valued at about $65,000. Blair William & Co. IL lifted its stake in shares of agilon health by 8.3% in the 1st quarter. Blair William & Co. IL now owns 242,076 shares of the company’s stock valued at $1,477,000 after acquiring an additional 18,599 shares during the last quarter. Vanguard Group Inc. boosted its holdings in agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after acquiring an additional 371,537 shares during the period. Finally, Seven Eight Capital LP bought a new position in agilon health during the 1st quarter worth approximately $1,593,000.

agilon health Stock Down 13.7 %

The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. The stock has a 50 day simple moving average of $3.22 and a 200 day simple moving average of $4.95. The firm has a market capitalization of $767.41 million, a PE ratio of -1.98 and a beta of 0.60.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%. During the same quarter in the prior year, the company earned ($0.06) earnings per share. As a group, sell-side analysts forecast that agilon health, inc. will post -0.32 earnings per share for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.